15893009

Source:http://linkedlifedata.com/resource/pubmed/id/15893009

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:15893009	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:15893009	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:15893009	lifeskim:mentions	umls-concept:C1516238	lld:lifeskim
pubmed-article:15893009	lifeskim:mentions	umls-concept:C0007131	lld:lifeskim
pubmed-article:15893009	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:15893009	lifeskim:mentions	umls-concept:C0935985	lld:lifeskim
pubmed-article:15893009	lifeskim:mentions	umls-concept:C0205269	lld:lifeskim
pubmed-article:15893009	pubmed:issue	3	lld:pubmed
pubmed-article:15893009	pubmed:dateCreated	2005-5-16	lld:pubmed
pubmed-article:15893009	pubmed:abstractText	This Phase II trial was designed to determine the response rate, survival, failure-free survival, and toxicity of second-line therapy with karenitecin in patients with relapsed or refractory non-small cell lung cancer (NSCLC).	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:language	eng	lld:pubmed
pubmed-article:15893009	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:15893009	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:15893009	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:15893009	pubmed:month	Jun	lld:pubmed
pubmed-article:15893009	pubmed:issn	0169-5002	lld:pubmed
pubmed-article:15893009	pubmed:author	pubmed-author:Cancer and...	lld:pubmed
pubmed-article:15893009	pubmed:author	pubmed-author:HerndonJames...	lld:pubmed
pubmed-article:15893009	pubmed:author	pubmed-author:GreenMark RMR	lld:pubmed
pubmed-article:15893009	pubmed:author	pubmed-author:KunZuZ	lld:pubmed
pubmed-article:15893009	pubmed:author	pubmed-author:MillerAntoniu...	lld:pubmed
pubmed-article:15893009	pubmed:issnType	Print	lld:pubmed
pubmed-article:15893009	pubmed:volume	48	lld:pubmed
pubmed-article:15893009	pubmed:owner	NLM	lld:pubmed
pubmed-article:15893009	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:15893009	pubmed:pagination	399-407	lld:pubmed
pubmed-article:15893009	pubmed:dateRevised	2007-11-14	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:meshHeading	pubmed-meshheading:15893009...	lld:pubmed
pubmed-article:15893009	pubmed:year	2005	lld:pubmed
pubmed-article:15893009	pubmed:articleTitle	Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004).	lld:pubmed
pubmed-article:15893009	pubmed:affiliation	Comprehensive Cancer Center of Wake Forest University, Medical Center Blvd., Winston-Salem, NC 27157, USA. aamiller@wfubmc.edu	lld:pubmed
pubmed-article:15893009	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:15893009	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:15893009	pubmed:publicationType	Research Support, U.S. Gov't, P.H.S.	lld:pubmed
pubmed-article:15893009	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed
pubmed-article:15893009	pubmed:publicationType	Research Support, N.I.H., Extramural	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15893009	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:15893009	lld:pubmed